![](/img/cover-not-exists.png)
Phase II Trial Evaluating the Palliative Benefit of Second-Line Zoledronic Acid in Breast Cancer Patients With Either a Skeletal-Related Event or Progressive Bone Metastases Despite First-Line Bisphosphonate Therapy
Clemons, M. J., Dranitsaris, G., Ooi, W. S., Yogendran, G., Sukovic, T., Wong, B. Y.L., Verma, S., Pritchard, K. I., Trudeau, M., Cole, D. E.C.Volume:
24
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2006.05.9212
Date:
September, 2006
File:
PDF, 165 KB
english, 2006